Earnings History Data for Cerevel Therapeutics Holdings, Inc. (CERE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Inc. treats neuroscience diseases. The company's diversified pipeline comprising clinical-stage investigational therapies and several preclinical compounds to treat neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics Inc., formerly known as Acquisition Corp II, is headquartered in Boston.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-11-2022 PM 6:15 AM ET
(Nov 8)
CERE Cerevel Therapeutics Holdings, Inc. 4,430 -0.66 -0.62 -0.43 Cerevel Therapeutics GAAP EPS of -$0.66 misses by $0.04
[11/8/2022 6:41 AM]
25.77 -1.34 
(-4.95%)
27.11 0.0 
(0.00%)
19.86 - 46.16 710,644 510,000 14,311
01-08-2022 PM 6:30 AM ET
(Aug 1)
CERE Cerevel Therapeutics Holdings, Inc. 3,960 -0.61 -0.50 -0.42 Cerevel Therapeutics GAAP EPS of -$0.61 misses by $0.13
[8/1/2022 6:19 AM]
27.62 1.33 
(5.06%)
26.29 0.0 
(0.00%)
19.86 - 46.16 342,901 470,000 14,580
10-05-2022 PM 6:30 AM ET
(May 10)
CERE Cerevel Therapeutics Holdings, Inc. 3,770 -0.46 -0.43 -0.40 Cerevel Therapeutics GAAP EPS of -$0.46
[5/10/2022 6:34 AM]
23.02 0.84 
(3.81%)
22.18 0.0 
(0.00%)
12.01 - 46.16 385,612 423,171 17,165
01-03-2022 PM 6:30 AM ET
(Mar 1)
CERE Cerevel Therapeutics Holdings, Inc. 3,750 -0.40 -0.41 -0.27 Cerevel Therapeutics GAAP EPS of -$0.40
[3/1/2022 6:33 AM]
28.30 1.83 
(6.89%)
26.47 0.0 
(0.00%)
12.01 - 46.16 369,272 570,000 11,527
10-11-2021 PM 6:30 AM ET
(Nov 10)
CERE Cerevel Therapeutics Holdings, Inc. 6,460 -0.43 -0.40 -4.83 Cerevel Therapeutics reports Q3 results
[11/10/2021 6:37 AM]
38.67 -4.75 
(-10.94%)
43.42 0.0 
(0.00%)
10.33 - 46.16 405,771 370,000 7,718
11-08-2021 PM 6:30 AM ET
(Aug 11)
CERE Cerevel Therapeutics Holdings, Inc. 3,580 -0.42 -0.41 0.00 Cerevel Therapeutics reports Q2 results
[8/11/2021 10:04 AM]
25.06 -0.50 
(-1.96%)
25.95 0.39 
(1.53%)
9.00 - 31.09 994,590 570,000 1,972
17-05-2021 PM 6:30 AM ET
(May 17)
CERE Cerevel Therapeutics Holdings, Inc. 1,700 -0.40 -0.45 0.00 Cerevel Therapeutics reports Q1 results
[5/17/2021 8:09 AM]
13.50 -0.10 
(-0.74%)
13.60 0.0 
(0.00%)
9.00 - 18.84 99,842 210,000 10,693
24-03-2021 PM 6:30 AM ET
(Mar 24)
CERE Cerevel Therapeutics Holdings, Inc. 2,260 -0.27 -0.37 0.00 Cerevel Therapeutics reports Q4 results
[3/24/2021 6:37 AM]
12.20 -5.39 
(-30.64%)
17.59 0.0 
(0.00%)
9.00 - 18.84 614,095 290,000 1,843